D-NMMA . monoacetate

CHF 55.00
In stock
AG-CR1-3580-M0055 mgCHF 55.00
AG-CR1-3580-M02525 mgCHF 155.00
AG-CR1-3580-M100100 mgCHF 465.00
More Information
Product Details
Synonyms NG-Monomethyl-D-arginine . monoacetate
Product Type Chemical
Properties
Formula

C7H16N4O2 . CH3COOH

MW 188.2 . 60.1
Merck Index 14: 6022
CAS 137694-75-8
Purity Chemicals ≥98%
Appearance White solid.
Solubility Soluble in water or methanol.
InChi Key IKPNWIGTWUZCKM-NUBCRITNBR
Smiles CC([O-])=O.CNC(=N)NCCC[C@@H]([NH3+])C(O)=O
Shipping and Handling
Shipping AMBIENT
Short Term Storage +4°C
Long Term Storage -20°C
Handling Advice Keep cool and dry.
Use/Stability Stable for at least 2 years after receipt when stored at -20°C.
Documents
MSDS Download PDF
Product Specification Sheet
Datasheet Download PDF
  • Cell permeable control compound for L-NMMA (Prod. No. AG-CR1-3578).
  • Inactive, shows no NOS inhibitor activity.
  • Useful tool to investigate non-specific L-NMMA activity.
Product References
  1. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo: D.D. Rees, et al.; Br. J. Pharmacol. 101, 746 (1990)
  2. Role of endothelium-formed nitric oxide on vascular responses: J. Marin J & C.F. Sanchez-Ferrer; Gen. Pharmacol. 21, 575 (1990)
  3. Inhibition of nitric oxide generation affects the induction of diabetes by streptozocin in mice: M.L. Lukic, et al.; BBRC 178, 913 (1991)
  4. The non specificity of specific nitric oxide synthase inhibitors: D.A. Peterson, et al.; BBRC 187, 797 (1992)
  5. Randomised double-blind placebo-controlled study of the effect of inhibition of nitric oxide synthesis in bradykinin-induced asthma: F.L. Ricciardolo, et al.; Lancet 348, 374 (1996)
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.